Results 101 to 110 of about 12,047 (282)

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

open access: yesInternational Journal of Infectious Diseases, 2020
Introduction: A possible increase in Candida resistance, especially in Candida glabrata, has been speculated according to poor diffusion of echinocandins to peritoneal fluid.
Francesca Gioia   +7 more
doaj   +1 more source

Invasive candidiasis as a cause of sepsis in the critically ill patient. [PDF]

open access: yes, 2013
Invasive fungal infections are an increasingly frequent etiology of sepsis in critically ill patients causing substantial morbidity and mortality. Candida species are by far the predominant agent of fungal sepsis accounting for 10% to 15% of health-care ...
Calandra, T., Delaloye, J.
core   +1 more source

The Importance of Early Mycological Clearance of Uncomplicated Candidaemia and Its Implications for Clinical Practice

open access: yesMycoses, Volume 68, Issue 12, December 2025.
ABSTRACT Invasive candidiasis is a life‐threatening infection associated with high morbidity, mortality and healthcare costs in both general and critical care settings. Timely diagnosis and adequate antifungal treatment are essential to improving patient outcomes and limiting unnecessary use of healthcare resources.
O. A. Cornely   +7 more
wiley   +1 more source

Anidulafungin-Induced Alopecia

open access: yesAnnals of Pharmacotherapy, 2014
Objetive: To report a case of a woman in whom alopecia appeared after several months of treatment with anidulafungin. Case Summary: A 34-year-old woman with chronic femoral osteomyelitis with the presence of persistent suppuration, developed a Candida albicans infection, isolated in the fistula exudate cultures.
Ruiz-Ramos J   +5 more
openaire   +3 more sources

Anidulafungin and Micafungin Concentrations in Cerebrospinal Fluid and in Cerebral Cortex

open access: yesAntimicrobial Agents and Chemotherapy, 2020
Anidulafungin and micafungin were quantified in cerebrospinal fluid (CSF) of critically ill adults and in cerebral cortex of deceased patients. In CSF, anidulafungin levels (
J. Marx   +10 more
semanticscholar   +1 more source

Mucormycosis in Paediatric Patients After Haematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis

open access: yesMycoses, Volume 68, Issue 12, December 2025.
ABSTRACT Background Data on the epidemiology, diagnostic methods and evidence‐based recommended treatment methods for children with mucormycosis who have undergone Haematopoietic stem cell transplantation (HSCT) are limited. Objective Summarise past recommendations and the latest literature on the treatment of HSCT in children with mucorin infection ...
Yujie Lei   +4 more
wiley   +1 more source

Invasive Candidiasis in Infants and Children: Recent Advances in Epidemiology, Diagnosis, and Treatment

open access: yesJournal of Fungi, 2019
This paper reviews recent advances in three selected areas of pediatric invasive candidiasis: epidemiology, diagnosis, and treatment. Although the epidemiological trends of pediatric invasive candidiasis illustrate a declining incidence, this infection ...
Thomas J. Walsh   +4 more
doaj   +1 more source

Effectiveness of an antifungal stewardship programme at a London teaching hospital 2010–16 [PDF]

open access: yes, 2019
Background The need for antifungal stewardship is gaining recognition with increasing incidence of invasive fungal infection (IFI) and antifungal resistance alongside the high cost of antifungal drugs.
Al-Ghusein, H   +9 more
core   +1 more source

Suramin, Penciclovir and Anidulafungin bind nsp12, which governs the RNA-dependent-RNA polymerase activity of SARS-CoV-2, with higher interaction energy than Remdesivir, indicating potential in the treatment of Covid-19

open access: yes, 2020
Structured abstract:Introduction: COVID-19, for which no vaccine or confirmed therapeutic agents are available, has claimed over 7,30,000 lives globally.
S. Dey   +7 more
semanticscholar   +1 more source

Safety of Rhizomucor pusillus biomass powder as a novel food pursuant to Regulation (EU) 2015/2283

open access: yesEFSA Journal, Volume 23, Issue 12, December 2025.
Abstract Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on the safety of the Rhizomucor pusillus biomass powder as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF is a filamentous fungus biomass powder. The novel food is intended for use
EFSA Panel on Nutrition   +29 more
wiley   +1 more source

Home - About - Disclaimer - Privacy